Expression characteristics of the human CD97 antigen

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• CD97 is a cell surface antigen upregulated upon leukocyte activation.
• Understanding CD97's structure and function provides insights into cellular activation events.

Purpose of the Study:

• To investigate the early and late regulation of CD97 expression on peripheral blood lymphocytes (PBL).
• To explore the signaling pathways involved in CD97 upregulation.
• To determine the expression pattern of CD97 in non-hematopoietic cells.

Main Methods:

• Stimulation of PBL with various agents.
• Inhibition studies using cycloheximide to assess protein synthesis dependence.
• Analysis of intracellular and surface CD97 expression.
• Investigation of signaling pathways (PKC, tyrosine kinase, Ca2+).
• Comparison of CD97 expression in PBL, Jurkat T cells, and non-hematopoietic cells.
• Detection of CD97 transcripts and protein via molecular techniques.

Main Results:

• Early CD97 upregulation on PBL is largely independent of de novo protein synthesis, involving protein redistribution.
• Later CD97 induction is dependent on de novo protein synthesis.
• CD97 upregulation involves protein kinase C-, tyrosine protein kinase-, and Ca2+-dependent pathways.
• Phorbol 12-myristate 13-acetate (PMA) differentially affects CD97 expression in PBL and Jurkat T cells.
• CD97 is expressed on non-hematopoietic cells, indicating it is not leukocyte-restricted.
• CD97 exists as differentially glycosylated forms (70-85 kDa) across cell types.

Conclusions:

• CD97 expression on leukocytes is dynamically regulated, involving both protein redistribution and synthesis.
• CD97 signaling pathways are complex and cell-type specific.
• CD97 is broadly distributed beyond leukocytes, with varied expression patterns.
• CD97 represents differentially glycosylated molecules with broad cellular distribution.